Loading clinical trials...
Loading clinical trials...
Phase III Study, Multi-center, Open, Randomized, to Assess the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood and Improvement of Quality of Life and Fatigue in Children Under Chemotherapy Treatment.
Conditions
Interventions
Erythropoietin
Start Date
May 1, 2023
Primary Completion Date
May 1, 2025
Completion Date
November 1, 2025
Last Updated
January 30, 2023
NCT07159659
NCT07169851
NCT07213804
NCT00026884
NCT05012111
NCT07481851
Research Operations
CONTACT
Lead Sponsor
Blau Farmaceutica S.A.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions